ADVERTISEMENT

No Pricing Relief For Indian Drugmakers Even As U.S. Faces Medicine Shortage

While shortages could have signalled hope for drug companies, allowing price hikes, the situation seems otherwise. Here's why

<div class="paragraphs"><p>Source: Unsplash</p></div>
Source: Unsplash
The U.S. drug shortage was at its worst since 2014 in the quarter ended March. While that should suggest better demand and pricing for Indian drugmakers battling competition in the American market, pharma companies and analysts see limited upside.Sun Pharmaceuticals Industries Ltd., India's largest drugmaker, said it has "not seen price stabilisation" in the period. This, the company's management said in its fourth-quarter earnings c...
To continue reading this story
Subscribe to unlock & enjoy all Members-only benefits

Choose a plan

Renews automatically. Cancel anytime.
Still Not convinced ? Know More